CMH Wealth Management LLC Buys Shares of 28,838 iShares Biotechnology ETF $IBB

CMH Wealth Management LLC purchased a new stake in iShares Biotechnology ETF (NASDAQ:IBB) during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor purchased 28,838 shares of the financial services provider’s stock, valued at approximately $5,485,000. CMH Wealth Management LLC owned 0.06% of iShares Biotechnology ETF as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also made changes to their positions in IBB. Dynamic Wealth Strategies LLC increased its holdings in iShares Biotechnology ETF by 16.6% in the fourth quarter. Dynamic Wealth Strategies LLC now owns 422 shares of the financial services provider’s stock valued at $71,000 after purchasing an additional 60 shares during the last quarter. Flagship Private Wealth LLC boosted its holdings in iShares Biotechnology ETF by 2.0% during the fourth quarter. Flagship Private Wealth LLC now owns 3,084 shares of the financial services provider’s stock worth $521,000 after buying an additional 60 shares during the last quarter. Larson Financial Group LLC boosted its holdings in iShares Biotechnology ETF by 2.3% during the fourth quarter. Larson Financial Group LLC now owns 2,717 shares of the financial services provider’s stock worth $458,000 after buying an additional 60 shares during the last quarter. Parallel Advisors LLC grew its position in shares of iShares Biotechnology ETF by 8.8% during the 1st quarter. Parallel Advisors LLC now owns 744 shares of the financial services provider’s stock worth $126,000 after buying an additional 60 shares during the period. Finally, Valmark Advisers Inc. grew its position in shares of iShares Biotechnology ETF by 3.2% during the 1st quarter. Valmark Advisers Inc. now owns 2,435 shares of the financial services provider’s stock worth $411,000 after buying an additional 75 shares during the period. 62.45% of the stock is currently owned by institutional investors.

iShares Biotechnology ETF Stock Up 0.0%

Shares of IBB stock opened at $209.05 on Tuesday. The stock has a 50-day moving average of $195.65 and a 200-day moving average of $179.17. iShares Biotechnology ETF has a one year low of $137.63 and a one year high of $217.12.

iShares Biotechnology ETF Cuts Dividend

The company also recently disclosed a quarterly dividend, which was paid on Thursday, June 18th. Investors of record on Monday, June 15th were issued a dividend of $0.0238 per share. The ex-dividend date was Monday, June 15th. This represents a $0.10 dividend on an annualized basis and a yield of 0.0%.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.